Thank you, Bill [Reeves] , for your generous introduction. I also thank all members of the Society for the confidence you placed in me, and to those for whom I had the pleasure to work with, for your collaboration. The addresses of several of my predecessors dealt with the issues of our Society and specialty. Bill Reeves in 1972 drew attention to the fact that our war against infectious diseases can be lost.' Karl Johnson assessed the Society's recent past, and its needs for the future.2 Phil Russell stressed that excel lence in research was not enough and that the development of practical applications and polit ical involvement were necessary to implement the results of research.3 Franz von Lichtenberg analyzed the diverse demographics of our Soci ety." Bill Scherer considered the dwindling sup ply of medical research scientists and suggested remedies;5 and Joe Cook discussed the challenge of tropical infectious disease problems in the de veloping world and in this country and whether we were able to meet it. 6 This challenge had been addressed also by the Report of the Board of Science and Technology for International De velopment (BOSTID) of the Institute of Medi cine and the National Academy of Sciences.7 Re cently, this BOSTID report was unanimously endorsed by the council of this Society. The ideas presented by my predecessors received positive response from many of us. Therefore, the time was right to work towards implementing some of the ideas proposed. To do this we need finan cial and human resources. During the business meeting to follow, we will review the Council's efforts to improve the financial position of the Society, to provide the basis for a larger journal, to enhance continuity of the Society's functions * Presidential Address given before the 37th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Washington, DC, 5 December 1988. by means of an executive secretary, and to de velop means for training and acquiring experi ence in tropical medicine as well as vector bi ology during peace time, in order to maintain and improve the United States' capacity to ad dress tropical disease problems.
For my presidential address I first considered the theme, "A Parasitologist Looks at Govern ment." After some consideration, however, I felt that I might not be able to present this serious subject with sufficient humor and without risk of offending at least some Washingtonians whose hospitality we enjoy.
What I propose to discuss today is the role that natural selection plays in shaping the world's population to withstand infectious diseases. I will also analyze the nature of immunity developed against individual infections, and consider what we can expect from vaccines.
During my professional career, the most pro vocative scientific event was the appearance of the acquired immunodeficiency syndrome, AIDS. During the last 8 years, society has been deeply affected by the AIDS phenomenon, and has changed to such a degree that some have won dered what we used to talk about before AIDS.
Although of tropical origin and involving both medicine and hygiene, AIDS differs vastly from the usual tropical and parasitic infections we have studied. We find ourselves confronted with novel phenomena and new challenges. To enumerate:
1. While severe immunodeficiency was known from congenital defects and as a consequence of tumor therapy, loss of the normally expected im munity to trivial infections was now produced by a communicable agent.
2. While a mild and temporary immunosuppression was known from several infections, an infection which progressively destroys the cellmediated immunity over a period of years was unheard of until AIDS was recognized. 336 FRENKEL 3. The infection is communicable during an unusually long incubation period, and during which time the etiological retrovirus is integrated into the genome of the infected cells. Its epide miologie investigation presents serious problems because we must look for a single blood or sexual exposure years ago.
4. Although specific antibodies to the virus have been serologically identified in stored hu man blood collected in Zaire in 1959,"â€¢ ' evidence suggested that we were dealing with a new disease that became pandemic in man for the first time. 10 5. The mysterious origin of the infection and all the reasons for its world-wide dissemination are not yet clear. The infection which may have originated in African monkeys has infected rural human beings sporadically." It was endemic, but controlled by social customs and geography. Tom Weller12 reviewed the effect of migration of rural African populations to the cities and the crea tions of large slums with a precarious social or ganization. There, the prevalence of heterosexually transmitted human immunodeficiency virus (HIV) infection, as measured serologically is high. 13 The rapid world-wide spread of the in fection was aided by frequent jet set travel, ho mosexual lifestyle in Europe and the Americas, widespread drug abuse, and blood transfusions, all modern phenomena compared to age-old sex. Hence the pandemic of AIDS is more a conse quence of over-rather than under-development, and of technology breaking natural and social barriers.
6. We have only a 7 year experience with the disease and 10 years of serologie data to draw from. For a while it seemed that perhaps only one-third of those infected might die. Recent evi dence, however, indicates this view was opti mistic and that a mortality rate of close to 100% over a period of years appears possible.14 Mor bidity data of seropositive men in San Francisco indicated that 48% developed AIDS during a pe riod of 10 years.15 Also when classifying HIV seropositive men by laboratory findings or the severity of clinical symptoms, Redfield and Burke found that 50-90% progressed from 1 stage to the next over a period of 36 months. 16 When attempting to extrapolate into the future, differ ent curve fitting techniques "predicted" that 71, 83, or even 100% of HIV infected men were to develop AIDS in 15 years.17 However, mathe matical projections do not take into account pathogenic mechanisms that differ in the first decade of infection and thereafter, a population that is genetically heterogeneous, and that an ab solute immunity may develop in a fraction of the population. Hence, we cannot predict. In fact, in a group of British homosexuals followed by Eales and colleagues18 " at St. Mary's Hospital in London, similar group specific components or GSC phenotypes were found in AIDS patients, and in seropositive men without disease, where as different GSC types were found in seronega tive men exposed by unprotected sexual contact with known AIDS patients. These data suggest possible resistance to infection and to expression of disease, perhaps because viral multiplication remains controlled, and because lymphocyte production remains adequate. Some of the forms of treatment, used and tried at present, may help. However, intercurrent infections may trigger expression of the integrated HIV genome in ac tivated CD4 lymphocytes at any time. 20 7. The spread of HIV infection to many com munities and its generally fatal course suggest that among highly infected and reproductive het erosexual populations, some will be selected for resistance to the human immunodeficiency vi rus. As just mentioned, what percentage of hu mans can resist infection or maintain an effective immunity is entirely uncertain.
The idea that humans can be selected for re sistance to disease has become strange to us in the Western world, and even asocial. The tech nologic control of excesses of heat and cold, flood and drought, the widespread control of infectious diseases, the medical management of formerly fatal diseases, such as diabetes and pernicious anemia, and the role of government in providing a safety net, led us to surmise that man was no longer subject to natural selection. However, we now recognize that modern air travel forges a bond between all parts of the world, providing ready contact with exotic infections, which can disseminate if ecologie circumstances are right. Rapid modern air travel, sexual promiscuity, and the drug culture were the ecologie preconditions of the AIDS pandemic.
More traditional ecologie factors in the trans mission of infection are well known and have been studied by members of our Society. With out the specific mosquito vector, malaria is not endemic; however, transplacental infection with Plasmodium malariae and Trypanosoma cruzi may occur in immigrants from countries where infection is endemic. Formerly rare transmission mechanisms can assume major importance when technology substitutes for absent insect vectors; and hepatitis B and sometimes malaria used to be transmitted by contaminated needles used for anti-syphilitic therapy, by serum additives as in the original yellow fever vaccine, by banked blood, or by homeopathic transfusions (from sharing of needles and syringes) amongst mem bers of the IV drug culture. On the other hand, the intelligent use of technology has made our blood supply reasonably safe.
We have seen how HIV, an exotic infectious agent, has spread in the U.S. and we can spec ulate what other infections can disseminate here. We have acquired foci of Aedes albopiclus, the "tiger mosquito," introduced with old tires from Asia in 16 major U.S. cities and 17 states, an example of world commerce spreading the means of infection, setting up base-line ecologie con ditions for the transmission of a number of vi ruses, such as La Crosse, dengue, Rift Valley fever, yellow fever, and others. This new vector complements the presence of Ae. aegypti along the Atlantic coast from the Virginias to Mexico. In the absence of the perfectionism of Fred Soper in his efforts to control mosquitoes, so vividly described by Tom Weller in his Soper lecture,21 we may be in for the surprises that Bill Reeves alluded to in his 1972 presidential address. 1 As a pathologist interested in infectious dis eases, I often ask myself, why does infection lead to illness, and what are the illness-producing fac tors in host and the microbe? Most of us are familiar with microbial factors of pathogenesis. However, the hosts, whether selected or unselected are of similar interest.
As we are living in a sea of microbes with about IO12organisms per gram of feces and about IO15 in the gut and on the skin of an average human, it is intuitively apparent that we evolved a ca pacity to manage both the number and diversity of organisms and that those genetically unable to do so have perished. We may ask, is there still evidence of natural selection by infectious dis eases, as I have postulated for AIDS?
Suggestive and perhaps metaphoric evidence comes from the asymptomatic occurrences of common microbes, such as Leptospira ballum in mice and rats. However, in an unnatural host, Golden hamsters, an acute generalized disease develops, with hepatitis and hemolysis, or de struction of the kidneys with uremia. 22 In hu mans, severe epidemics of measles, malaria, and influenza in isolated areas are sometimes cited as evidence of a lack of selection. In Hawaii, the bird population has been decimated by intro duced bird malaria and bird pox and the mos quitoes which transmit them. 23 It is difficult to prove the selection process from anecdotal evidence; we need controls or quan titative data, as provided by the prevalence of certain genetic traits in different human popu lations.
In a study of malarious populations, Allison proposed that the increased frequency of the sickle cell trait indicated natural selection.24 P. falciparum does not utilize hemoglobin-S (HbS) as readily as the normal HbAA. In 1-year-old chil dren with similar infection rates, the mortality in the HbS carriers is lower than in the homozygous HbAA. Clinical attacks are shorter in 1-5-year-old children with HbSA than in those with HbAA. The selective advantage of heterozygous HbS carriers is shown by their increasing per centage in the population, from about 8% in in fants to over 20% in adulthood in areas where falciparum malaria is endemic. It appears that the gene frequency of HbS hÃ©tÃ©rozygotes will in crease until couterbalanced by the disadvantage of the homozygous sickle cell disease state. 25 It struck me as curious that neotropical mon keys and Australian marsupials in zoos often die of toxoplasmosis.26-27 Because cats are essential for the occurrence of toxoplasmosis,28 it was rea sonable to assume that the Australian marsupials had not been selected for resistance, because they evolved in the absence of cats. Cats were intro duced to Australia only about 200 years ago (B. L. Munday, Mt. Pleasant Laboratories, Dept. of Agriculture, Tasmania, personal communica tion). Consulting Darlington's Zoogeography,291 learned that cats had also been absent from Mad agascar, and there are indeed several reports from zoos of fatal toxoplasmosis among Madagascan lemurs. 30 That neotropical monkeys were so prone to develop fatal toxoplasmosis also suggested a lack of exposure to cats and selection. We found that although about half of various ground-feeding animals in Panama had antibody to Toxoplasma, only 1 of 50 monkeys did.31 In nature, the ground-feeders are exposed to Toxoplasma oocysts shed in the feces of cats, while the ar boreal monkeys are not. As shown both in zoo epidemics and experimental studies, these South American monkeys do not readily develop im-munity and hence die from toxoplasmosis in zoos. 26 Even after exposure to a low pathogenic live vaccine, marmosets and Aotus monkeys have difficulty resisting challenge. This suggests a lack of evolutionary experience with Toxoplasma and lack of natural selection for being able to develop a strong immunity. 32 We recently had the opportunity to study the sera of some 40 arboreal African green monkeys, in which only 5% had Toxoplasma antibody, whereas in a group of 50 terrestrial Chinese rhe sus monkeys, 40% had antibody. As yet we have no data concerning the immune potential of these 2 groups.
How quickly can genetically pleomorphic hosts be selected and consequently develop resistance to a microbe not previously encountered? Be cause hosts are selected by Toxoplasma mainly in zoos, and because these infections are sporadic and do not transmit further, we have no oppor tunity to learn from such happenings. And what ever selection occurred during the 200 years of feline exposure in Australia has not been studied. One might consider toxoplasmosis in kangaroos living in close contact with cats near cities, in comparison with relatively isolated popula tions, such as in the central Australian desert. Such studies might give us some information on the speed with which kangaroos are selected by Toxoplasma.
Informative studies of myxoma virus infection in rabbits are often cited. This virus is indigenous to the Americas where it produces a benign fi broma in Sylvilagus. However, when infecting European rabbits (Oryctolagus cuniculus) either in Australia or in Europe, an almost uniformly fatal disease developed.33 Surprisingly, after only 2 years, a few immune surviving rabbits were found. During the succeeding 30 years, the mor tality rate varied between 90% in rabbits never exposed, and about 30% in rabbits from popu lations exposed to several prior epidemics. 33 Because of their much longer generation time, humans are selected more slowly than other an imals. Tuberculosis is still a more serious disease in American Indians first exposed in the 16th century than in Europeans and their descendants who were probably selected by the infection for a much longer period of time. I would also expect a higher morbidity rate with toxoplasmosis in Australian aborigines than in other human pop ulations, however I know of no data concerning this.
Recognizing that the genetic endowment to de velop immunity is so important, let us now turn our attention to the type of immunity that can be achieved by the human host. It is axiomatic that obligate parasitic microbes have developed a way to persist in the population. Microbes per sist in immune hosts as chronic infection, or in vector such as mosquitoes, ticks, or other arthopods, or in another host, such as monkeys for yellow fever and rodents for plague. Alterna tively, microbes sustain themselves as "child hood diseases" or cyclic epidemics involving the susceptibe fraction of the population. This "strategy" is usually seen when sterile immunity is achieved.
In Table 1 , I have categorized the types of immunity seen with severe infections. I have never seen such a classification. Perhaps it will be of interest to you and I hope it will stimulate disagreement and refinement of these clinicoimmunologic concepts.
Myxoma is either fatal in rabbits between 13 and about 50 days, or a sterile immunity devel ops and the virus disappears. Smallpox in hu mans behaved similarly; it was fatal to some, but if immunity developed the virus disappeared. This was one of the reasons that smallpox was eradicated. 34 However, in tuberculosis, toxoplasmosis, and CMV infection, immunity is partial, and is associated with chronic infection. Such infec tion-immunity, concomitant immunity, or premunition35-36 is the result of long co-evolu tion of host and microbe. Chronicity is essential for these obligate parasites to persist. Between the extremes of sterile immunity and infectionimmunity, there is measles which gives rise to sterile immunity in most humans, except in an instructive few who develop subacute sclerosing panencephalitis. Varicella produces sterile im munity in some and infection-immunity in oth ers, who may develop zoster as a recurrent in fection. 37 Let us now consider the infections regularly followed by infection-immunity. In group 1, im munity is generally acquired promptly, it is good, although immunosuppression may precipitate a relapse; examples are toxoplasmosis, pneumocystosis, herpes simplex, histoplasmosis, and ep idemic typhus. In group 2, immunity is acquired more slowly and it appears more vulnerable to immunosuppression as exemplified by tubercu losis, hepatitis, and cytomegalovirus infection. In group 3, we see chronic infection with labile immunity because of microbial variation, such as in the malarias, spirochetal relapsing fever, and T. brucei infections. The trypanosome in fections are of interest because they produce mild infections in native animals, but give rise to se vere infection in domestic ruminants, especially in recently introduced stock, suggesting co-evo lution of trypanosomes and native hosts.25 Group 4 consists of chronic infections with a fair degree of immunity in most tissues, but with an immune defect in one body compartment. So we find that while antibody lyses cryptococcal capsules in the lung, the portal of entry, infection progresses in the brain, probably because of the low IgG diffusion. African trypanosomes are cleared from most of the body except the brain, where the Rhodesian variant is especially pro gressive. In another subgroup, immunity is corticoid-labile; so that after adrenal localization, there is progressive multiplication of tubercle ba cilli, Histoplasma, or cytomegalovirus. This can lead to the development of Addison's disease if adrenocortical regeneration is insufficient.38 Generalized immunity is also sensitive to hypercorticism induced for a variety of therapeutic purposes in this group, as in groups 1 and 2. Another subgroup shows localization of the in fection in the skin such as with dermal leishmaniasis, leprosy and a few cases of blastomycosis. It is my impression that this resulted from defects of expressing immunity in the cooler parts of the body.
Group 5 consists of infections in which im munity is clearly incomplete. In a small per centage of people, hepatitis B infection remains chronically active, leading to progressive damage of the liver and polyarteritis nodosum and glomerulonephritis with persistent infection. Im munity to HIV is defective in many or most humans, with persistent proviral DNA in the host genome. After a period of seeming immu nity, there follows progressive destruction of lymphoid tissues, especially the T-4 subset of lymphocytes, which, possibly together with hu man herpes type 6 and other viruses, leads to immunosuppression, a compromised host. This permits infection with a variety of organisms; these are either endogenous agents of chronic infections, such as CMV, herpes, Toxoplasma, and Pneumocystis; or they are exogenous mi crobes, such as Histoplasma, Aspergillus, Entamoeba, Cryptosporidium, or ???Mycobacterium avium-intracellulare. These exogenous agents can be either first infections or re-infec tions.
Classifying infection by the type and degree of immunity developed is useful in predicting clin ical behavior. We may ask, can it predict eradicability and vaccine responses? I believe yes, when qualified answers are given. All infections with a sterile immunity can be eradicated pro vided that man is the only host, immunity is effective in all body compartments, and all sus ceptibles can be reached and immunized. Small pox has thus been eradicated and it is hoped that measles will soon follow. The slow human re productive rate permitted time for vaccination, and the presence of an immune population, herd immunity, prevented further spread. Myxoma in rabbits, although similar in many respects, in fects a host that is so prolific that immunologically naive hosts are born several times each year, permitting the virus to persist. What would hap pen if all rabbits were benevolently immunized soon after birth? The infection would probably die out. As shown with ectromelia by Topley,39 the effect of herd immunity would be sufficient to protect the group, allowing for even a few conscientious objectors to vaccination.39"
One might suspect that poliovirus could be eliminated; however intestinal immunity does not appear good enough to curb viral prolifera tion to the degree seen in smallpox. Therefore while the disease of the central nervous system can be prevented, poliovirus infection persists in the population after exposure to killed vaccine. Even though there is humoral immunity, the in testine is still susceptible. However, oral vacci nation with live vaccine appears to immunize the vaccine and the vaccine strains replace the wild poliovirus strains in the intestine. 40 Although producing a sterile immunity, yellow fever, western equine encephalitis, and Rocky Mountain spotted fever have animal hosts which are impractical to either immunize completely or to eradicate, and therefore endemicity will persist. Cryptococcosis cannot be eradicated be cause the fungus grows in the environment. Mea sles appears eradicatale by adequate immuniza tion and the few who develop subacute sclerosing panencephalitis do not have communicable in fections. However, with varicella, the population pool with chronic infection may be sufficiently large, so that those who develop zoster maintain the virus in the human population. This im-mimologie hypothesis can be tested in near future when varicella vaccine will be licensed in the United States.
Can the naturally acquired immunity also pre dict the immunity achievable by immunization? Agents that are followed by sterile immunity should, after vaccination with a good antigenic cocktail, also develop sterile immunity, and even after challenge, be followed again by sterile im munity.
For infections leading to premunition, vacci nation is aimed at protecting against illness, not infection. The non-persistent Toxoplasma vac cine candidate ts-4 is a good example; it produces good immunity in laboratory animals, and we learned from it that immunity to Toxoplasma is not dependent on chronic infection. It protects against illness from challenge.41"43 However, challenge is followed by persistence of the chal lenge organism. The vaccine for cats inhibits oocyst shedding and thereby reduces dissemi nation.44 The 2 vaccines might be used together for a local toxoplasmosis control program. We hope to test this in Panama. The clinical efficacy of various vaccines against normally persistent organisms, the malarias, leishmaniasis, Chagas' disease, and several helminthic infections re main to be demonstrated.
The outlook for protection by vaccines for in fections usually accompanied by premunition is not good. However, we have at least one ex ample, feline leukemia, where the normally per sistent infection can be prevented by vaccine. Protective and immunosuppressive antigens were identified and after separating these, vaccination with the protective antigens produced satisfac tory immunity. 45 This prolonged virus infection of cats, similar to HTLV-1 infection of man, gives rise to leu kemia. In this interesting feline model, the virus is also commonly incorporated into the genome of infected cells. However, immunization with the protective antigens inhibits viral multipli cation to such a degree that opportunities for incorporation and development of leukemia were practically precluded. This successful subunit vaccine suggests testing for immunosuppressive qualities all of the many non-protective antigens of other infectious agents which give rise to pre munition. If such are found, they could be ex cluded from the antigenic cocktail used as vac cine. This could lead to the preparation of a more highly protective vaccine, and hopefully, sterile immunity rather than infection-immunity will follow. We would also learn more about the de terminants of infection-immunity.
We must also consider that most of the infec tions accompanied by infection-immunity are controlled more by cellular immunity than by antibody-related effects. It would be important therefore to identify putative protective antigens not only by antibody responses. Testing for the production of protective lymphokines, specific as well as non-specific, could lead to a better selection of antigens for a vaccine. 46 I have reviewed some aspects of the novel pathogenesis of HIV infection, and the proba bility that man is selected by it. I have also pre sented a classification of the clinical types of im munity produced, and speculated on the immunity achievable by vaccines. The tropical infectious disease problems are quite diverse and staggering where they exist. I have not discussed selection of microbes such as of falciparum ma laria for drug resistanceâ€"which is always on going, and so far dwarfs AIDS in importance. Certainly, modern travel tends to expose the U.S. population to foreign microbes more frequently. The AIDS outbreak is only the first major intro duction of an exotic infection. Dengue, yellow fever, Rift Valley fever may be waiting, and the vector mosquitoes are here already.
We have an exciting future for the study and problem solving problems ahead of us. Because preventing the spread of infections requires sus tained efforts and because eradication can only be achieved for some infections and regionally, a reservoir of competent experts is required to achieve and maintain these goals. The political initiative proposed by the Society is to assure the adequate training and experience of a critical mass of medical and vector biology specialists as a national resource. To be successful, individuals of this Society need to maintain commitment and leadership, responsibility in argument, and crosscultural teaching of the electorate and its representatives. The 2 culture phenomenon of C. P. Snow47 is still with us. Field study, shoe leather epidemiology, ecologie biology, and com mon sense born by experience are still necessary in an age of molecular biology and immunology, a 3 trillion dollar deficit, nuclear deterrence, and star war fantasies.
But in a sense we cannot lose and the future of tropical medicine is bright. We will either be controlling infections, or be diagnosing and treat-ing them. In the interest of potential victims, I hope that this Society, through its political ef forts, can become more effective in the control, prevention, and even eradication of infectious diseases worldwide. But if we must continue to fight imported epidemics, and spreading epidem ics elsewhere, we may join the group of ultimate growth industries: garbage disposal and govern ment bureaucracy. And then, the sun never sets on tropical medicine.
